title: Ischemic preconditioning mediated by activation of KATP channels in rat small intestine.
abstract: OBJECTIVE
  To study whether the protective effects of ischemic preconditioning against rat small intestine ischemia/reperfusion injury could be mediated by KATP channel opener.
  
  
  METHODS
  Preconditioning (Pc) was induced by 3 cycles of 8-min superior mesenteric artery (SMA) occlusion and 10-min reperfusion before prolonged ischemia. Cromakalim (Cro 75 micrograms.kg-1) and glibenclamide (Gli 8 mg.kg-1) were injected i.v. 10 min before prolonged ischemia and Pc, respectively.
  
  
  RESULTS
  Compared with ischemic reperfusion (IR) group, Pc before prolonged ischemia (Pc + IR) decreased LDH release [(380 +/- 55) vs (559 +/- 49) U.L-1, P < 0.05], attenuated intestinal edema [wet weight/dry weight (WW/DW), 5.6 +/- 0.6 vs 6.34 +/- 0.29, P < 0.05], ameliorated intestinal histological damage (grading scale, 3.4 vs 5.7, P < 0.01), and improved reperfusion-induced hypotension. These effects of Pc were mimicked by Cro [LDH, (298 +/- 40) vs (559 +/- 49) U.L-1, P < 0.05; WW/DW, 5.6 +/- 0.4 vs 6.34 +/- 0.29, P < 0.05; grading scale, 3.6 vs 5.7, P < 0.01] and abolished in the presence of Gli [LDH, (624 +/- 44) vs (559 +/- 49) U.L-1; WW/DW, 6.6 +/- 0.6 vs 6.34 +/- 0.29; grading scale, 5.7 vs 5.7; P > 0.05] compared with IR group, respectively.
  
  
  CONCLUSIONS
  Ischemic preconditioning on the rat small intestine is mediated by activation of KATP channels.
authors.affiliation: Department of Pharmacology, Shanxi Medical University, Taiyuan, China.
authors.forename: S P
authors.initials: SP
authors.lastname: Yang
authors.forename: Y B
authors.initials: YB
authors.lastname: Hao
authors.forename: Y X
authors.initials: YX
authors.lastname: Wu
authors.forename: W
authors.initials: W
authors.lastname: Dun
authors.forename: L H
authors.initials: LH
authors.lastname: Shen
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
mesh_terms: D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D019806:Cromakalim / Q000494:pharmacology*; D005905:Glyburide / Q000494:pharmacology; D007421:Intestine, Small / Q000098:blood supply* / Q000473:pathology; D019194:Ischemic Preconditioning; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000201:enzymology / Q000473:pathology
chemical_list: D015221:Potassium Channels; D019806:Cromakalim; D000255:Adenosine Triphosphate; D007770:L-Lactate Dehydrogenase; D005905:Glyburide